SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-003671
Filing Date
2022-03-15
Accepted
2022-03-15 16:24:37
Documents
64
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apre-20211231x10k.htm   iXBRL 10-K 2280181
2 EX-21.1 apre-20211231xex21d1.htm EX-21.1 5358
3 EX-23.1 apre-20211231xex23d1.htm EX-23.1 5912
4 EX-31.1 apre-20211231xex31d1.htm EX-31.1 17803
5 EX-31.2 apre-20211231xex31d2.htm EX-31.2 16560
6 EX-32.1 apre-20211231xex32d1.htm EX-32.1 5308
7 EX-32.2 apre-20211231xex32d2.htm EX-32.2 5616
8 GRAPHIC apre-20211231x10k001.jpg GRAPHIC 52366
9 GRAPHIC apre-20211231x10k002.jpg GRAPHIC 9697
10 GRAPHIC apre-20211231x10k003.jpg GRAPHIC 15285
  Complete submission text file 0001558370-22-003671.txt   6658374

Data Files

Seq Description Document Type Size
11 EX-101.SCH apre-20211231.xsd EX-101.SCH 34258
12 EX-101.CAL apre-20211231_cal.xml EX-101.CAL 41258
13 EX-101.DEF apre-20211231_def.xml EX-101.DEF 136551
14 EX-101.LAB apre-20211231_lab.xml EX-101.LAB 382827
15 EX-101.PRE apre-20211231_pre.xml EX-101.PRE 271389
58 EXTRACTED XBRL INSTANCE DOCUMENT apre-20211231x10k_htm.xml XML 827971
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39069 | Film No.: 22741416
SIC: 2834 Pharmaceutical Preparations